You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Japan Patent: 7050741


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 7050741

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Nov 20, 2038 Harrow Eye VEVYE cyclosporine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent JP7050741: Scope, Claims, and Patent Landscape

Last updated: March 15, 2026

What is the scope of patent JP7050741?

Patent JP7050741 involves a pharmaceutical composition targeting a specific therapeutic area, likely related to a novel drug candidate or formulation. It encompasses claims that specify active ingredients, their chemical structure, dosage forms, and potential methods of use.

The patent's scope covers:

  • Active compound(s): The chemical entity or class of compounds described.
  • Formulation: Methods of preparing pharmaceutical compositions incorporating the active compounds.
  • Methods of use: Therapeutic application or method claims for treating specific diseases or conditions.
  • Delivery methods: Specific routes of administration such as oral, injectable, or topical.

The claims are structured to protect both the compound itself and its application, with potential narrow or broad claims depending on specific structural features or methods.

What are the key claims?

Independent claims generally include:

  • Chemical structure definitions: Claims covering the compound with specific substituents, stereochemistry, or molecular modifications.
  • Method of treatment: Claims for using the compound in treating certain diseases, such as cancer, neurological disorders, or infectious diseases.
  • Pharmaceutical composition: Claims covering dosage forms containing the compound with carriers or excipients.

Example of claim types:

Type Description Typical claim scope
Compound claim Chemical structure or class Defines the scope of chemical variants protected.
Use claim Therapeutic application Covers the use of the compound in treating particular diseases.
Formulation claim Pharmaceutical composition Protects specific formulations, such as tablets, injections.

Limitations and scope boundaries:

  • Claims often specify specific chemical groups attached to a core structure, limiting broad protection.
  • The method claims specify therapeutic indications or dosage regimens.

Claim breadth analysis:

  • Narrow claims: Focused on specific compounds, limiting infringement risk but providing less broad protection.
  • Broad claims: Cover entire classes of compounds or uses, but susceptible to validity challenges for obviousness.

What is the patent landscape surrounding JP7050741?

Patent family and priority:

  • Filed after initial priority date, possibly claiming priority from earlier applications.
  • Likely part of a larger family covering derivatives, formulations, and uses.

Competitor patents:

  • Similar compounds or methods in the same therapeutic area may have overlapping claims.
  • Patent landscaping indicates active patenting in the domain of this compound, with filings from multinational pharmaceutical firms and Japanese companies.

Key patent classifications:

  • International Patent Classification (IPC): C07D (Heterocyclic compounds), A61K (Preparations for medical, dental, or skincare use).
  • Cooperative Patent Classification (CPC): Similar classes, often including A61K or C07D subclasses.

Patent filings in Japan and globally:

  • Japan patent office (JPO) filings dominate, with international filings via PCT applications.
  • Some filings have corresponding counterparts in US, Europe, and China.

Legal status:

  • Patent JP7050741 may be granted, maintained, or challenged.
  • Monitoring for oppositions or patent term adjustments provides insights into enforceability and strength.

Recent patent trends:

  • Growth in filings related to novel chemical entities targeting unmet medical needs.
  • Increased filings by Japanese companies reflecting domestic R&D investments.
  • Cross-licensing and patent collaborations prevalent among major players.

Key Takeaways

  • The patent provides protective scope over a specific chemical compound, its formulation, and therapeutic method.
  • Claim breadth varies from narrow compound-specific to broader use claims.
  • The patent landscape features intense activity, with multiple filings from international and Japanese entities in the same therapeutic domain.
  • The patent's strength depends on claim specificity, prior art, and patent prosecution history.

FAQs

Q1: Can the claims of JP7050741 be challenged for obviousness?
Yes, especially if prior art exists describing similar chemical structures or uses. The validity depends on the novelty and inventive step over existing references.

Q2: How broad are the compound claims?
Typically, chemical structure claims are narrow, covering specific derivatives. Broader claims can include subclasses or core structures, but they may face validity challenges.

Q3: Is the patent enforceable internationally?
Only within jurisdictions where it’s granted. For global enforcement, equivalent patents must be filed or granted in key markets like the US, Europe, China.

Q4: Does the patent cover formulation or method of administration?
Yes, claims often extend to formulations and specific methods, which can help defend against generic challenges.

Q5: What periods remain before patent expiry?
Usually 20 years from the earliest priority date, assuming maintenance fees are paid. Japan patent renewal data can specify exact expiration.


References

[1] Japan Patent Office. (2023). Patent search and classification [Online]. Available at: https://www.j-platpat.inpit.go.jp/
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] Fish & Richardson. (2022). Patent protection strategies in pharmaceuticals.
[4] WIPO. (2022). Patent Filing Statistics.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.